Estrogen stimulates transcription of human immunodeficiency virus type 1 (HIV-1)

International Immunopharmacology

Volumn 6, Issue 2, 2006, Pages 170-181

  Katagiri, Daichi ^a   Hayashi, Hidetoshi ^a   Victoriano, Ann Florence B ^b   Okamoto, Takashi ^b   Onozaki, Kikuo ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Estrogen; Estrogen receptor; HIV; NF B; Sp1

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CELL STRAIN HEK293; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; GC RICH SEQUENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATIONAL ANALYSIS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; VIRUS TRANSCRIPTION;

BLOTTING, WESTERN; CELLS, CULTURED; DNA, VIRAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; HIV-1; HUMANS; INDICATORS AND REAGENTS; MUTATION; NF-KAPPA B; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); VIRUS REPLICATION;

EID: 30144442639     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.07.017     Document Type: Article

References (50)

1. M. Mahathir Women at greater risk of HIV infection Arrows Change 3 1997 1 2
2. P. Schuman, and J.D. Sobel Women and AIDS Aust N Z J Obstet Gynaecol 32 1993 341 350
3. [No authors] Being young and vulnerable to contracting HIV. At-risk populations Sex Wkly Plus vol. 5 1996 Sample No
4. C.E. Bush, R.M. Donovan, N. Markowitz, D. Baxa, P. Kvale, and L.D. Saravolatz Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia J Clin Microbiol 34 1996 970 972
5. K. Anastos, S.J. Gange, B. Lau, B. Weiser, R. Detels, and J.V. Giorgi Association of race and gender with HIV-1 RNA levels and immunologic progression J Acquir Immune Defic Syndr 24 2000 218 226
6. T.R. Sterling, C.M. Lyles, D. Vlahov, J. Astemborski, J.B. Margolick, and T.C. Quinn Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters J Infect Dis 180 1999 666 672
7. L. Castagnetta, O.M. Granata, A. Traina, L. Cocciadiferro, A. Saetta, and R. Stefano A role for sex steroids in autoimmune diseases: a working hypothesis and supporting data Ann NY Acad Sci 966 2002 193 203
8. S. Ogawa, S. Inoue, T. Watanabe, H. Hiroi, A. Orimo, and T. Hosoi The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro Biochem Biophys Res Commun 243 1998 122 126
9. P. Walter, S. Green, G. Greene, A. Krust, J.M. Bornert, and J.M. Jeltsch Cloning of the human estrogen receptor cDNA Proc Natl Acad Sci U S A 82 1985 7889 7893
10. M. Sabbah, S. Le Ricouss, G. Redeuilh, and E.E. Baulieu Estrogen receptor-induced bending of the Xenopus vitellogenin A2 gene hormone response element Biochem Biophys Res Commun 185 1992 944 952
11. J.F. Savouret, A. Bailly, M. Misrahi, C. Rauch, G. Redeuilh, and A. Chauchereau Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene EMBO J 10 1991 1875 1883
12. D. Dubik, and R.P. Shiu Mechanism of estrogen activation of c-myc oncogene expression Oncogene 7 1992 1587 1594
13. W. Porter, B. Saville, D. Hoivik, and S. Safe Functional synergy between the transcription factor Sp1 and the estrogen receptor Mol Endocrinol 11 1997 1569 1580
14. J.R. Schultz, L.N. Petz, and A.M. Nardulli Estrogen receptor alpha and Sp1 regulate progesterone receptor gene expression Mol Cell Endocrinol 201 2003 165 175
15. T. Suzuki, A. Kimura, R. Nagai, and M. Horikoshi Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding Genes Cells 5 2000 29 41
16. C. Teyssier, K. Belguise, F. Galtier, and D. Chalbos Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding J Biol Chem 276 2001 36361 36369
17. B. Stein, and M.X. Yang Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta Mol Cell Biol 15 1995 4971 4979
18. M.H. Faulds, K. Pettersson, J.A. Gustafsson, and L.A. Haldosen Cross-talk between ERs and signal transducer and activator of transcription 5 is E2 dependent and involves two functionally separate mechanisms Mol Endocrinol 15 2001 1929 1940
19. T. Hayashi, Y. Ueno, and T. Okamoto Oxidoreductive regulation of nuclear factor kappa B involvement of a cellular reducing catalyst thioredoxin J Biol Chem 268 1993 11380 11388
20. T. Okamoto, T. Benter, S.F. Josephs, R.M. Sadaie, and F. Wong-Staal Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro Virology 177 1990 606 614
21. N.D. Perkins, A.F. Agranoff, E. Pascal, and G.J. Nabel An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation Mol Cell Biol 14 1994 6570 6583
22. S. Kanazawa, T. Okamoto, and B.M. Peterlin Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection Immunity 12 2000 61 70
23. J. Karn Tackling tat J Mol Biol 293 1999 235 254
24. H. Okamoto, C.T. Sheline, J.L. Corden, K.A. Jones, and B.M. Peterlin Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II Proc Natl Acad Sci U S A 93 1996 11575 11579
25. T. Sato, K. Asamitsu, J.P. Yang, N. Takahashi, T. Tetsuka, and A. Yoneyama Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride AIDS Res Hum Retroviruses 14 1998 293 298
26. N. Takada, T. Sanda, H. Okamoto, J.P. Yang, K. Asamitsu, and L. Sarol RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actions J Virol 76 2002 8019 8030
27. M.J. West, A.D. Lowe, and J. Karn Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation J Virol 75 2001 8524 8537
28. L.M. Botella, T. Sanchez-Elsner, F. Sanz-Rodriguez, S. Kojima, J. Shimada, and M. Guerrero-Esreo Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury Blood 100 2002 4001 4010
29. F. Ohtake, K. Takeyama, T. Matsumoto, H. Kitagawa, Y. Yamamoto, and K. Nohara Modulation of oestrogen receptor signalling by association with the activated dioxin receptor Nature 423 2003 545 550
30. C. Chen, and H. Okayama High-efficiency transformation of mammalian cells by plasmid DNA Mol Cell Biol 7 1987 2745 2752
31. H. Uranishi, T. Tetsuka, T. Yamashita, K. Asamitsu, M. Shimizu, and M. Itoh Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator J Biol Chem 276 2001 13395 13401
32. T. Okamoto, H. Ogiwara, T. Hayashi, A. Mitsui, T. Kawabe, and J. Yodoi Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism Int Immunol 4 1992 811 819
33. J.P. Yang, J.P. Merin, T. Nakano, T. Kato, Y. Kitade, and T. Okamoto Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro FEBS Lett 361 1995 89 96
34. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
35. T. Matsumura, H. Hayashi, T. Takii, C.F. Thorn, A.S. Whitehead, and J. Inoue TGF-beta down-regulates IL-1alpha-induced TLR2 expression in murine hepatocytes J Leukoc Biol 7 2004 1056 1061
36. V. Rider, and N.I. Abdou Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus Int Immunopharmacol 1 2001 1009 1024
37. G.G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggblad, and S. Nilsson Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 1997 863 870
38. J. Arts, G.G. Kuiper, J.M. Janssen, J.A. Gustafsson, C.W. Lowik, and H.A. Pols Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells Endocrinology 138 1997 5067 5070
39. H. Hiroi, S. Inoue, T. Watanabe, W. Goto, A. Orimo, and M. Momoeda Differential immunolocalization of estrogen receptor alpha and beta in rat ovary and uterus J Mol Endocrinol 22 1999 37 44
40. H. Ohata, T. Tetsuka, H. Hayashi, K. Onozaki, and T. Okamoto 3-methylcholanthrene activates human immunodeficiency virus type 1 replication via aryl hydrocarbon receptor Microbiol Immunol 47 2003 363 370
41. G. Sun, W. Porter, and S. Safe Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex Mol Endocrinol 12 1998 882 890
42. S. Jackson, T. Gottlieb, and K. Hartley Phosphorylation of transcription factor Sp1 by the DNA-dependent protein kinase Adv Second Messenger Phosphoprotein Res 28 1993 279 286
43. X. Yang, K. Su, M.D. Roos, Q. Chang, A.J. Paterson, and J.E. Kudlow O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability Proc Natl Acad Sci U S A 98 2001 6611 6616
44. K. Reisinger, R. Kaufmann, and J. Gille Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription J Cell Sci 116 Pt 2 2003 225 238
45. D. Trisciuoglio, A. Iervolino, A. Candiloro, G. Fibbi, and M. Fanciulli bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity J Biol Chem 279 2004 6737 6745
46. E. Benasciutti, G. Pages, O. Kenzior, W. Folk, F. Blasi, and M.P. Crippa MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription Blood 104 2004 256 262
47. J. Laurence, H. Cooke, and S.K. Sikder Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1 Blood 75 1990 696 703
48. F. Mesange, F. Delarue, J. Puel, F. Bayard, and J.C. Faye Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes Mol Pharmacol 50 1996 75 79
49. B. Saville, M. Wormke, F. Wang, T. Nguyen, E. Enmark, and G. Kuiper Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements J Biol Chem 275 2000 5379 5387
50. K.L. Phiel, R.A. Henderson, S.J. Adelman, and M.M. Elloso Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations Immunol Lett 97 2005 107 113